Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.
There are only a few reports of pulmonary hypertension (PH) in hypersensitivity pneumonitis (HP) and an approved vasomodulatory therapy for PH does not exist at all for interstitial lung disease (ILD), particularly for HP. The case of a 53-year-old woman with chronic HP and severe life-threatening PH treated with a combined specific vasomodulatory therapy is reported. Sustained clinical and hemodynamic improvement was achieved. Further investigation of PH in HP and specific vasomodulatory therapy is necessary.